-
1
-
-
0034305965
-
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer
-
Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-45.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3339-3345
-
-
Brizel, D.M.1
Wasserman, T.H.2
Henke, M.3
Strnad, V.4
Rudat, V.5
Monnier, A.6
-
2
-
-
78650630193
-
Prevention and treatment of radiation injuries - The role of the renin-angiotensin system
-
Rubin P, Constine LS, Mark LP, Okunieff P, editors. Heidelberg: Springer-Verlag
-
Cohen EP, Joines MM, Moulder JE. Prevention and treatment of radiation injuries - The role of the renin-angiotensin system. In: Rubin P, Constine LS, Mark LP, Okunieff P, editors. Late effects of cancer treatment on normal tissues. Heidelberg: Springer-Verlag; 2008. p. 69-76.
-
(2008)
Late Effects of Cancer Treatment on Normal Tissues
, pp. 69-76
-
-
Cohen, E.P.1
Joines, M.M.2
Moulder, J.E.3
-
4
-
-
55349084049
-
Medical countermeasures against nuclear threats: Radionuclide decorporation agents
-
Cassatt DR, Kaminski JM, Hatchett RJ, DiCarlo AL, Benjamin JM, Maidment BW, et al. Medical countermeasures against nuclear threats: radionuclide decorporation agents. Radiat Res 2008;170:540-8.
-
(2008)
Radiat Res
, vol.170
, pp. 540-548
-
-
Cassatt, D.R.1
Kaminski, J.M.2
Hatchett, R.J.3
DiCarlo, A.L.4
Benjamin, J.M.5
Maidment, B.W.6
-
5
-
-
44849121666
-
Medical countermeasures for radiation combined injury: Radiation with burn, blast, trauma and/or sepsis
-
report of an NIAID Workshop, March 26-27, 2007
-
DiCarlo AL, Hatchett RJ, Kaminski JM, Ledney GD, Pellmar TC, Okunieff P, et al. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26-27, 2007. Radiat Res 2008;169:712-21.
-
(2008)
Radiat Res
, vol.169
, pp. 712-721
-
-
DiCarlo, A.L.1
Hatchett, R.J.2
Kaminski, J.M.3
Ledney, G.D.4
Pellmar, T.C.5
Okunieff, P.6
-
6
-
-
33947512453
-
Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury
-
Moulder JE, Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol 2007;17:141-8.
-
(2007)
Semin Radiat Oncol
, vol.17
, pp. 141-148
-
-
Moulder, J.E.1
Cohen, E.P.2
-
7
-
-
58149328417
-
The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment
-
Robbins ME, Payne V, Tommasi E, Diz DI, Hsu FC, Brown WR, et al. The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys 2009;73:499-505.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.73
, pp. 499-505
-
-
Robbins, M.E.1
Payne, V.2
Tommasi, E.3
Diz, D.I.4
Hsu, F.C.5
Brown, W.R.6
-
8
-
-
79251515940
-
Total body irradiation-induced increase in risk factors for cardiovascular disease are mitigated by post irradiation treatment with losartan and curcumin
-
Lawrence (KS): Radiation Research Society
-
Baker JE, Fish B, Moulder JE. Total body irradiation-induced increase in risk factors for cardiovascular disease are mitigated by post irradiation treatment with losartan and curcumin. Proceedings of the 55th Annual Meeting of the Radiation Research Society ; 2009 Oct 4-7; Savannah (GA). Lawrence (KS): Radiation Research Society; 2010;143.
-
(2010)
Proceedings of the 55th Annual Meeting of the Radiation Research Society; 2009 Oct 4-7; Savannah (GA)
, pp. 143
-
-
Baker, J.E.1
Fish, B.2
Moulder, J.E.3
-
9
-
-
42949109332
-
Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice
-
Brown SL, Kolozsvary A, Liu J, Ryu S, Kim JH. Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice. Radiat Res 2008;169:474-8.
-
(2008)
Radiat Res
, vol.169
, pp. 474-478
-
-
Brown, S.L.1
Kolozsvary, A.2
Liu, J.3
Ryu, S.4
Kim, J.H.5
-
10
-
-
34547429997
-
Simvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanism
-
Wang J, Boerma M, Fu Q, Kulkarni A, Fink LM, Hauer-Jensen M. Simvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanism. Int J Radiat Oncol Biol Phys 2007;68:1483-90.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.68
, pp. 1483-1490
-
-
Wang, J.1
Boerma, M.2
Fu, Q.3
Kulkarni, A.4
Fink, L.M.5
Hauer-Jensen, M.6
-
11
-
-
9244246263
-
Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries
-
Report of an NCI Workshop, December 3-4, 2003
-
Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res 2004;162:711-28.
-
(2004)
Radiat Res
, vol.162
, pp. 711-728
-
-
Stone, H.B.1
Moulder, J.E.2
Coleman, C.N.3
Ang, K.K.4
Anscher, M.S.5
Barcellos-Hoff, M.H.6
-
12
-
-
77953452311
-
Advances and perspectives in the molecular diagnosis of head and neck cancer
-
Mydlarz WK, Hennessey PT, Califano JA. Advances and perspectives in the molecular diagnosis of head and neck cancer. Expert Opin Med Diagn 2010;4:53-65.
-
(2010)
Expert Opin Med Diagn
, vol.4
, pp. 53-65
-
-
Mydlarz, W.K.1
Hennessey, P.T.2
Califano, J.A.3
-
13
-
-
23844559204
-
The scientific basis of radiotherapy
-
Tannock I, Hill RP, Bristow RG, Harrington L, editors. 4th ed. New York: McGraw-Hill Medical Publishing Company
-
Hill RP, Brisotw RG. The scientific basis of radiotherapy. In: Tannock I, Hill RP, Bristow RG, Harrington L, editors. The basic science of oncology. 4th ed. New York: McGraw-Hill Medical Publishing Company; 2005. p.289-323.
-
(2005)
The Basic Science of Oncology
, pp. 289-323
-
-
Hill, R.P.1
Brisotw, R.G.2
-
14
-
-
0036283219
-
The radiotherapeutic injury-a complex 'wound'
-
Denham JW, Hauer-Jensen M. The radiotherapeutic injury-a complex 'wound'. Radiother Oncol 2002;63:129-45.
-
(2002)
Radiother Oncol
, vol.63
, pp. 129-145
-
-
Denham, J.W.1
Hauer-Jensen, M.2
-
15
-
-
22144444484
-
Molecular markers predicting radiotherapy response: Report and recommendations from an International Atomic Energy Agency technical meeting
-
West CM, McKay MJ, Holscher T, Baumann M, Stratford IJ, Bristow RG, et al. Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. Int J Radiat Oncol Biol Phys 2005;62:1264-73.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.62
, pp. 1264-1273
-
-
West, C.M.1
McKay, M.J.2
Holscher, T.3
Baumann, M.4
Stratford, I.J.5
Bristow, R.G.6
-
16
-
-
74549176997
-
Establishment of a radiogenomics consortium
-
West C, Rosenstein BS. Establishment of a radiogenomics consortium. Radiother Oncol 2010;94:117-8.
-
(2010)
Radiother Oncol
, vol.94
, pp. 117-118
-
-
West, C.1
Rosenstein, B.S.2
-
17
-
-
0034320191
-
Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice
-
Zheng H, Wang J, Koteliansky VE, Gotwals PJ, Hauer-Jensen M. Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice. Gastroenterology 2000;119:1286-96.
-
(2000)
Gastroenterology
, vol.119
, pp. 1286-1296
-
-
Zheng, H.1
Wang, J.2
Koteliansky, V.E.3
Gotwals, P.J.4
Hauer-Jensen, M.5
-
18
-
-
34848891816
-
Targeting transforming growth factor-beta signaling
-
DOI 10.1097/CCO.0b013e3282f0ad0e, PII 0000162220071100000007
-
Pennison M, Pasche B. Targeting transforming growth factor-beta signaling. Curr Opin Oncol 2007;19:579-85. (Pubitemid 47508864)
-
(2007)
Current Opinion in Oncology
, vol.19
, Issue.6
, pp. 579-585
-
-
Pennison, M.1
Pasche, B.2
-
20
-
-
5044223266
-
Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways
-
viii
-
Wachsberger P, Burd R, Dicker AP. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways. Hematol Oncol Clin North Am 2004;18:1039-57[viii.].
-
(2004)
Hematol Oncol Clin North Am
, vol.18
, pp. 1039-1057
-
-
Wachsberger, P.1
Burd, R.2
Dicker, A.P.3
-
21
-
-
51349098155
-
Cytokines as a key component of cancer-related inflammation
-
Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine 2008;43:374-9.
-
(2008)
Cytokine
, vol.43
, pp. 374-379
-
-
Germano, G.1
Allavena, P.2
Mantovani, A.3
-
22
-
-
35548987432
-
Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor
-
DOI 10.1667/RR0707.1
-
Kohl RR, Kolozsvary A, Brown SL, Zhu G, Kim JH. Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor. Radiat Res 2007;168:440-5. (Pubitemid 351303172)
-
(2007)
Radiation Research
, vol.168
, Issue.4
, pp. 440-445
-
-
Kohl, R.R.1
Kolozsvary, A.2
Brown, S.L.3
Zhu, G.4
Kim, J.H.5
-
23
-
-
0042074154
-
Celecoxib reduces skin damage after radiation: Selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor
-
Liang L, Hu D, Liu W, Williams JP, Okunieff P, Ding I. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Am J Clin Oncol 2003;26:S114-21.
-
(2003)
Am J Clin Oncol
, vol.26
-
-
Liang, L.1
Hu, D.2
Liu, W.3
Williams, J.P.4
Okunieff, P.5
Ding, I.6
-
24
-
-
3042763035
-
Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model
-
Williams JP, Hernady E, Johnston CJ, Reed CM, Fenton B, Okunieff P, et al. Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model. Radiat Res 2004;161:560-7.
-
(2004)
Radiat Res
, vol.161
, pp. 560-567
-
-
Williams, J.P.1
Hernady, E.2
Johnston, C.J.3
Reed, C.M.4
Fenton, B.5
Okunieff, P.6
-
25
-
-
77955881529
-
Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: Results from CaPSURE
-
Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int 2010;106:627-32.
-
(2010)
BJU Int
, vol.106
, pp. 627-632
-
-
Katz, M.S.1
Carroll, P.R.2
Cowan, J.E.3
Chan, J.M.4
D'Amico, A.V.5
-
26
-
-
0034054128
-
Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker
-
Molteni A, Moulder JE, Cohen EF, Ward WF, Fish BL, Taylor JM, et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol 2000;76:523-32. (Pubitemid 30232452)
-
(2000)
International Journal of Radiation Biology
, vol.76
, Issue.4
, pp. 523-532
-
-
Molteni, A.1
Moulder, J.E.2
Cohen, E.F.3
Ward, W.F.4
Fish, B.L.5
Taylor, J.M.6
Wolfe, L.F.7
Brizio-Molteni, L.8
Veno, P.9
-
27
-
-
71649101555
-
Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis
-
Ghosh SN, Zhang R, Fish BL, Semenenko VA, Li XA, Moulder JE, et al. Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys 2009;75:1528-36.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.75
, pp. 1528-1536
-
-
Ghosh, S.N.1
Zhang, R.2
Fish, B.L.3
Semenenko, V.A.4
Li, X.A.5
Moulder, J.E.6
-
28
-
-
33947194301
-
Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: Importance of ramipril dose and treatment time
-
DOI 10.1007/s11060-006-9256-4
-
Ryu S, Kolozsvary A, Jenrow KA, Brown SL, Kim JH. Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: importance of ramipril dose and treatment time. J Neurooncol 2007;82:119-24. (Pubitemid 46431853)
-
(2007)
Journal of Neuro-Oncology
, vol.82
, Issue.2
, pp. 119-124
-
-
Ryu, S.1
Kolozsvary, A.2
Jenrow, K.A.3
Brown, S.L.4
Kim, J.H.5
-
29
-
-
40949138809
-
Captopril to Mitigate Chronic Renal Failure after Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial
-
DOI 10.1016/j.ijrobp.2007.08.041, PII S0360301607039922
-
Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, et al. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 2008;70:1546-51. (Pubitemid 351417757)
-
(2008)
International Journal of Radiation Oncology Biology Physics
, vol.70
, Issue.5
, pp. 1546-1551
-
-
Cohen, E.P.1
Irving, A.A.2
Drobyski, W.R.3
Klein, J.P.4
Passweg, J.5
Talano, J.-A.M.6
Juckett, M.B.7
Moulder, J.E.8
-
30
-
-
33645689430
-
Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands
-
Lombaert IM, Wierenga PK, Kok T, Kampinga HH, deHaan G, Coppes RP. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clin Cancer Res 2006;12:1804-12.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1804-1812
-
-
Lombaert, I.M.1
Wierenga, P.K.2
Kok, T.3
Kampinga, H.H.4
DeHaan, G.5
Coppes, R.P.6
-
31
-
-
0035854479
-
Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice
-
DOI 10.1126/science.1060191
-
Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001;293:293-7. (Pubitemid 32694744)
-
(2001)
Science
, vol.293
, Issue.5528
, pp. 293-297
-
-
Paris, F.1
Fuks, Z.2
Kang, A.3
Capodieci, P.4
Juan, G.5
Ehleiter, D.6
Haimovitz-Friedman, A.7
Cordon-Cardo, C.8
Kolesnick, R.9
-
32
-
-
75749114436
-
p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis
-
Kirsch DG, Santiago PM, di Tomaso E, Sullivan JM, Hou WS, Dayton T, et al. p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science 2010;327:593-6.
-
(2010)
Science
, vol.327
, pp. 593-596
-
-
Kirsch, D.G.1
Santiago, P.M.2
Di Tomaso, E.3
Sullivan, J.M.4
Hou, W.S.5
Dayton, T.6
-
33
-
-
64549122013
-
Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources
-
Williston Park
-
Vikram B, Coleman CN, Deye JA. Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources. Oncology 2009;23:279-83[Williston Park].
-
(2009)
Oncology
, vol.23
, pp. 279-283
-
-
Vikram, B.1
Coleman, C.N.2
Deye, J.A.3
-
34
-
-
0025939587
-
Tolerance of normal tissue to therapeutic irradiation
-
Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
-
(1991)
Int J Radiat Oncol Biol Phys
, vol.21
, pp. 109-122
-
-
Emami, B.1
Lyman, J.2
Brown, A.3
Coia, L.4
Goitein, M.5
Munzenrider, J.E.6
-
35
-
-
70349770964
-
Radiotherapy: IMRT reduces xerostomia and potentially improves QoL
-
Eisbruch A. Radiotherapy: IMRT reduces xerostomia and potentially improves QoL. Nat Rev Clin Oncol 2009;6:567-8.
-
(2009)
Nat Rev Clin Oncol
, vol.6
, pp. 567-568
-
-
Eisbruch, A.1
-
36
-
-
76049120553
-
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy
-
Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010;76:775-81.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.76
, pp. 775-781
-
-
Liao, Z.X.1
Komaki, R.R.2
Thames Jr., H.D.3
Liu, H.H.4
Tucker, S.L.5
Mohan, R.6
-
38
-
-
77949407113
-
The missing voice of patients in drug-safety reporting
-
Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med 2010;362:865-9.
-
(2010)
N Engl J Med
, vol.362
, pp. 865-869
-
-
Basch, E.1
-
39
-
-
70350238222
-
-
DCTD, NCI, NIH, DHHS, Available from updated 15 April 2010; accessed 4 June 2010
-
Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v4.0, DCTD, NCI, NIH, DHHS. Available from: http://ctep.cancer. gov/protocolDevelopment/electronic-applications/docs/ctcae-index.pdf#search= "common terminology". [updated 15 April 2010; accessed 4 June 2010.]
-
Common Terminology Criteria for Adverse Events V4.0
-
-
-
40
-
-
36849093844
-
Patient-reported outcomes and the evolution of adverse event reporting in oncology
-
Trotti A, Colevas AD, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 2007;25:5121-7.
-
(2007)
J Clin Oncol
, vol.25
, pp. 5121-5127
-
-
Trotti, A.1
Colevas, A.D.2
Setser, A.3
Basch, E.4
-
41
-
-
33746261692
-
-
U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research Washington: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research
-
U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. Washington: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 2009.
-
(2009)
Guidance for Industry Patient-reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims
-
-
-
42
-
-
77951626978
-
Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: Randomized RTOG trial 0315
-
Zachariah B, Gwede CK, James J, Ajani J, Chin LJ, Donath D, et al. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315. J Natl Cancer Inst 2010;102:547-56.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 547-556
-
-
Zachariah, B.1
Gwede, C.K.2
James, J.3
Ajani, J.4
Chin, L.J.5
Donath, D.6
-
43
-
-
52449091099
-
Designing phase 0 cancer clinical trials
-
Murgo AJ, Kummar S, Rubinstein L, Gutierrez M, Collins J, Kinders R, et al. Designing phase 0 cancer clinical trials. Clin Cancer Res 2008;14:3675-82.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3675-3682
-
-
Murgo, A.J.1
Kummar, S.2
Rubinstein, L.3
Gutierrez, M.4
Collins, J.5
Kinders, R.6
-
44
-
-
20244383481
-
Randomized trial of amifostine in locally advanced non-smallcell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation therapy oncology group trial 98-01
-
Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, et al. Randomized trial of amifostine in locally advanced non-smallcell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 2005;23:2145-54.
-
(2005)
J Clin Oncol
, vol.23
, pp. 2145-2154
-
-
Movsas, B.1
Scott, C.2
Langer, C.3
Werner-Wasik, M.4
Nicolaou, N.5
Komaki, R.6
-
45
-
-
0038071449
-
Does amifostine have a role in chemoradiation treatment?
-
Brizel DM, Overgaard J. Does amifostine have a role in chemoradiation treatment?Lancet Oncol 2003;4:378-81.
-
(2003)
Lancet Oncol
, vol.4
, pp. 378-381
-
-
Brizel, D.M.1
Overgaard, J.2
-
46
-
-
56349137675
-
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: An analysis of RTOG 9801
-
Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, et al. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 2008;72:1378-84.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 1378-1384
-
-
Sarna, L.1
Swann, S.2
Langer, C.3
Werner-Wasik, M.4
Nicolaou, N.5
Komaki, R.6
-
47
-
-
33750305266
-
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study
-
Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 2006;7:903-9.
-
(2006)
Lancet Oncol
, vol.7
, pp. 903-909
-
-
Basch, E.1
Iasonos, A.2
McDonough, T.3
Barz, A.4
Culkin, A.5
Kris, M.G.6
-
48
-
-
33645959171
-
The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires
-
Jensen K, Bonde JA, Grau C. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 2006;78:298-305.
-
(2006)
Radiother Oncol
, vol.78
, pp. 298-305
-
-
Jensen, K.1
Bonde, J.A.2
Grau, C.3
-
49
-
-
1542562988
-
Outcomes research in cancer clinical trial cooperative groups: The RTOG model
-
Bruner DW, Movsas B, Konski A, Roach M, Bondy M, Scarintino C, et al. Outcomes research in cancer clinical trial cooperative groups: the RTOG model. Qual Life Res 2004;13:1025-41.
-
(2004)
Qual Life Res
, vol.13
, pp. 1025-1041
-
-
Bruner, D.W.1
Movsas, B.2
Konski, A.3
Roach, M.4
Bondy, M.5
Scarintino, C.6
-
50
-
-
76449112804
-
Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: The importance of dose-volume effects
-
Bentzen SM, Parliament M, Deasy JO, Dicker A, Curran WJ, Williams JP, et al. Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects. Int J Radiat Oncol Biol Phys 2010;76:S145-50.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.76
-
-
Bentzen, S.M.1
Parliament, M.2
Deasy, J.O.3
Dicker, A.4
Curran, W.J.5
Williams, J.P.6
-
51
-
-
53249111808
-
The Translational Research Working Group developmental pathways: Introduction and overview
-
Hawk ET, Matrisian LM, Nelson WG, Dorfman GS, Stevens L, Kwok J, et al. The Translational Research Working Group developmental pathways: introduction and overview. Clin Cancer Res 2008;14:5664-71.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5664-5671
-
-
Hawk, E.T.1
Matrisian, L.M.2
Nelson, W.G.3
Dorfman, G.S.4
Stevens, L.5
Kwok, J.6
-
52
-
-
53249155163
-
The Translational Research Working Group developmental pathway for lifestyle alterations
-
Hawk ET, Greenwood A, Gritz ER, McTiernan A, Sellers T, Hursting SD, et al. The Translational Research Working Group developmental pathway for lifestyle alterations. Clin Cancer Res 2008;14:5707-13.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5707-5713
-
-
Hawk, E.T.1
Greenwood, A.2
Gritz, E.R.3
McTiernan, A.4
Sellers, T.5
Hursting, S.D.6
|